Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Cash from Financing Activities (2013 - 2026)

Xencor (XNCR) posted quarterly Cash from Financing Activities of $950000.0 for Q1 2026, down 23.94% year-over-year from $1.2 million in Q1 2025, and down 84.97% quarter-over-quarter from $6.3 million in Q4 2025.

Analysis

Xencor (XNCR) Cash from Financing Activities (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Cash from Financing Activities for 14 consecutive years, with $950000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 23.94% year-over-year to $950000.0; the TTM figure through Mar 2026 stood at $7.9 million (down 95.97% YoY), while the FY2025 annual figure was $8.2 million, down 95.82% from the prior year.
  • Cash from Financing Activities fell to $950000.0 in Q1 2026 per XNCR's latest filing, from $6.3 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $189.9 million in Q3 2024 and bottomed at $356000.0 in Q3 2023.
  • Historically, Cash from Financing Activities has averaged $25.1 million across 5 years, with a median of $1.3 million in 2022.
  • On a YoY basis, Cash from Financing Activities climbed as much as 53232.58% in 2024 and fell as far as 97.62% in 2024.
  • Xencor's Cash from Financing Activities stood at $1.2 million in 2022, then surged by 15785.57% to $186.0 million in 2023, then tumbled by 97.62% to $4.4 million in 2024, then surged by 42.65% to $6.3 million in 2025, then tumbled by 84.97% to $950000.0 in 2026.
  • Business Quant data shows XNCR's Cash from Financing Activities at $950000.0 in Q1 2026, $6.3 million in Q4 2025, and $662000.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 14.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.42 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -6.05 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 36.24 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -273.15 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 27.18 Mn
10 Xencor 2.02 Bn 1.65 Bn - 1.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.03 Mn
Mar 31, 2026 950,000.00
Dec 31, 2025 6.32 Mn
Jun 30, 2025 662,000.00
Mar 31, 2025 1.25 Mn
Dec 31, 2024 4.43 Mn
Sep 30, 2024 189.86 Mn
Jun 30, 2024 1.07 Mn
Mar 31, 2024 1.79 Mn
Dec 31, 2023 186.02 Mn
Sep 30, 2023 356,000.00
Jun 30, 2023 1.92 Mn
Mar 31, 2023 922,000.00
Dec 31, 2022 1.17 Mn
Sep 30, 2022 1.29 Mn
Jun 30, 2022 2.51 Mn
Mar 31, 2022 731,000.00
Dec 31, 2021 32.63 Mn
Sep 30, 2021 3.23 Mn
Jun 30, 2021 1.84 Mn